Netherlands vs Sweden: Share of S. aureus infections resistant to methicillin
Netherlands
2.3%
in 2022
Sweden
1.9%
in 2022
Netherlands rank
42nd
Sweden rank
43rd
Share of S. aureus infections resistant to methicillin over time
- Netherlands
- Sweden
How they compare
Netherlands currently reports 2.3% against 1.9% in Sweden, a difference of 0.4%.
That makes Netherlands's figure about 1.2 times Sweden's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Netherlands ahead.
Netherlands ranks 42nd and Sweden ranks 43rd of 45 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.6% | 0.2% | Sweden |
| 2020s | 1.8% | 3.0% | 1.2% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Netherlands or Sweden?
- Netherlands, at 2.3% against 1.9% in Sweden as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Netherlands and Sweden?
- 0.4%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Sweden?
- 6 years are reported by both, from 2017 to 2022.
- How do Netherlands and Sweden rank globally for share of s. aureus infections resistant to methicillin?
- Netherlands ranks 42nd and Sweden ranks 43rd of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).